Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-24-199818
Filing Date
2024-08-13
Accepted
2024-08-13 16:34:04
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-3 d792594ds3.htm S-3 158171
2 EX-5.1 d792594dex51.htm EX-5.1 4090
3 EX-23.2 d792594dex232.htm EX-23.2 2508
4 EX-FILING FEES d792594dexfilingfees.htm EX-FILING FEES 16297
5 GRAPHIC g792594g0813122941683.jpg GRAPHIC 5802
6 GRAPHIC g792594g21u88.jpg GRAPHIC 4381
7 GRAPHIC g792594g79d59.jpg GRAPHIC 73935
  Complete submission text file 0001193125-24-199818.txt   298530
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 212-994-8250
MiNK Therapeutics, Inc. (Filer) CIK: 0001840229 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-281522 | Film No.: 241202249
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)